AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit

Autor: Lin, Tzu-Yin, Fenger, Joelle, Murahari, Sridhar, Bear, Misty D., Kulp, Samuel K., Wang, Dasheng, Chen, Ching-Shih, Kisseberth, William C., London, Cheryl A. *
Zdroj: In Blood 27 May 2010 115(21):4217-4225
Databáze: ScienceDirect